Want to see AU:ICR full AI Analyst Report?
ICR Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.04
Previous CloseN/A
Volume1.07K
Average Volume (3M)1.91M
Market Cap
AU$12.88M
Enterprise ValueAU$0.00
Total Cash (Recent Filing)AU$1.05M
Total Debt (Recent Filing)AU$1.09M
Price to Earnings (P/E)―
Beta-0.14
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding715,306,760
10 Day Avg. Volume3,223,113
30 Day Avg. Volume1,908,177
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-3.27
Price to Sales (P/S)2.85
P/FCF Ratio-1.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA ~45% top-line rebound to ~A$0.96m in FY2025 demonstrates the business can grow revenue from its current base. Sustained revenue expansion would enable better absorption of fixed costs, create scale for margin recovery, and provide a more durable platform for reaching profitability.
Improving Cash BurnThe reduction in cash outflows versus prior years and an operating cash flow of ~-A$1.67m in FY2025 indicate management is narrowing the cash deficit. If this trend persists alongside revenue growth, it represents a durable improvement in operational control and lowers near-term funding intensity.
Modest Absolute DebtAbsolute borrowings of ~A$0.72m versus ~A$1.02m of assets mean debt is not outsized for the company scale. For a small healthcare‑software operator this contained leverage reduces fixed interest burdens and preserves potential refinancing or structured capital options, providing some balance-sheet flexibility.
Bears Say
Negative Gross ProfitNegative gross profit signals the core product/service is loss-making at current prices and scale. This undermines margin sustainability: achieving durable profitability will require material pricing changes, cost restructuring, or significantly higher volumes—each a structural challenge over months.
Negative Shareholders' EquityNegative equity reflects cumulative losses that have eroded the capital base, raising solvency and funding risk. This condition constrains borrowing capacity, increases the likelihood of dilutive capital raises or creditor concessions, and materially limits strategic flexibility over the medium term.
Persistent Operating LossesOngoing operating losses and sustained negative operating cash flow mean the company continues to burn cash and depend on external funding. Without a credible, sustained shift to positive cash generation, this structural weakness will pressure liquidity, force dilution, and restrict investment in growth initiatives.
InteliCare Holdings Limited News
ICR FAQ
What was InteliCare Holdings Limited’s price range in the past 12 months?
InteliCare Holdings Limited lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is InteliCare Holdings Limited’s market cap?
InteliCare Holdings Limited’s market cap is AU$12.88M.
When is InteliCare Holdings Limited’s upcoming earnings report date?
InteliCare Holdings Limited’s upcoming earnings report date is Sep 02, 2026 which is in 35 days.
How were InteliCare Holdings Limited’s earnings last quarter?
InteliCare Holdings Limited released its earnings results on Feb 26, 2026. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is InteliCare Holdings Limited overvalued?
According to Wall Street analysts InteliCare Holdings Limited’s price is currently Overvalued.
Does InteliCare Holdings Limited pay dividends?
InteliCare Holdings Limited does not currently pay dividends.
What is InteliCare Holdings Limited’s EPS estimate?
InteliCare Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InteliCare Holdings Limited have?
InteliCare Holdings Limited has 715,306,760 shares outstanding.
What happened to InteliCare Holdings Limited’s price movement after its last earnings report?
InteliCare Holdings Limited reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of InteliCare Holdings Limited?
Currently, no hedge funds are holding shares in AU:ICR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
InteliCare Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
136.36%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-14.68%
Trailing 12-Months
Company Description
InteliCare Holdings Limited
Operating out of Leederville, Australia, Intelicare Holdings Limited was founded in 2016. The company is dedicated to supplying innovative predictive analytics solutions, delivered as a combined hardware and software package, primarily serving Australia's aged care and health industries. Among its key offerings are InteliLiving, tailored to assist seniors and individuals with disabilities, and a specialized monitoring system designed for the elderly and other vulnerable populations.
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Beamtree Holdings Ltd
―
Alcidion Group Limited
―
PainChek Ltd
―
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh
―